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Abstract
Background—Systemic ethanol administration increases neuroactive steroid levels that increase
ethanol sensitivity. Acetaldehyde is a biologically active compound that may contribute to
behavioral and rewarding effects of ethanol. We investigated the role of acetaldehyde in ethanol–
induced elevations of 3α-hydroxy-5α-pregnan-20-one (3α,5α-THP) levels in cerebral cortex.
Methods—Male Sprague-Dawley rats were administered ethanol and plasma acetaldehyde
concentrations were measured by gas chromatography to determine relevant concentrations. Rats
were then administered acetaldehyde directly, acetaldehyde plus cyanamide to block its
degradation, or ethanol in the presence of inhibitors of ethanol metabolism, to determine effects on
3α,5α-THP levels in cerebral cortex.
Results—Ethanol administration (2 g/kg) to rats results in a peak acetaldehyde concentration of
6-7 μM at 10 minutes that remains stable for the duration of the time points tested. Direct
administration of acetaldehyde eliciting this plasma concentration does not increase cerebral
cortical 3α,5α-THP levels and inhibition of ethanol-metabolizing enzymes to modify acetaldehyde
formation does not alter ethanol–induced 3α,5α-THP levels. However, higher doses of
acetaldehyde (75 and 100 mg/kg), in the presence of cyanamide to prevent its metabolism, are
capable of increasing cortical 3α,5α-THP levels.
Conclusions—Physiological concentrations of acetaldehyde are not responsible for ethanol-
induced increases in 3α,5α-THP, but a synergistic role for acetaldehyde with ethanol may
contribute to increases in 3α,5α-THP levels and ethanol sensitivity.
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INTRODUCTION
Neuroactive steroids produce their effects on membrane receptors that regulate central
nervous system activity rather than nuclear receptors that regulate gene expression. The 3α,
5α-reduced pregnan steroids, including 3α-hydroxy-5α-pregnan-20-one (3α,5α-THP) and
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3α,21-dihydroxy-5α-pregnan-20-one (3α,5α-THDOC), are endogenous modulators of
GABA-A receptors and produce rapid changes in central nervous system activity (for review
Belelli and Lambert, 2005). The GABA-A receptor system is the primary inhibitory receptor
system in the brain and is responsible for many behavioral effects of ethanol. Systemic
ethanol administration increases plasma and brain levels of neuroactive steroids (Morrow et
al., 1999; VanDoren et al., 2000) that can act with nanomolar potency on GABA-A
receptors (Morrow et al., 1987; Puia et al., 1990).
Neuroactive steroids can be synthesized de novo in the brain or produced peripherally in the
adrenals and gonads. While ethanol-induced increases in neuroactive steroids can originate
from both adrenal glands and brain, the adrenal glands are a major source of neuroactive
steroids and their precursors. Indeed, adrenalectomy reduces neuroactive steroid levels in
plasma and brain and prevents ethanol-induced elevations. However, administration of 5α-
dihydroprogesterone, the immediate precursor of the potent GABAergic neurosteroid 3α,5α-
THP, to adrenalectomized animals restores ethanol-induced elevations of cortical 3α,5α-
THP (Khisti et al., 2003) suggesting an important role for both adrenal and brain
steroidogenesis. In addition, studies have demonstrated brain steroidogenesis in
adrenalectomized animals given time for recovery (Follesa et al., 2006) as well as in cell
culture (Hu et al., 1987). Indeed, all of the steroidogenic biosynthetic enzymes are present in
brain and have been shown to colocalize in specific cell types (King et al., 2002).
Ethanol increases rat plasma and brain concentrations of the neuroactive steroids 3α,5α-THP
and 3α,5α-THDOC, which are potent GABAergic modulators that can elicit many of the
same effects as ethanol (Barbaccia et al., 1999; Morrow et al., 1999). The maximal effect of
ethanol on neuroactive steroid levels is observed at 2.5 g/kg ethanol. Ethanol-induced
increases in GABAergic neuroactive steroids are requisite for anxiolytic (Hirani et al., 2005)
and anticonvulsant (VanDoren et al., 2000) effects of ethanol and contribute to sedative-
hypnotic actions (Khisti et al., 2003) and spatial learning impairment (Matthews et al.,
2002). In addition, electrophysiological effects of ethanol in medial septal and hippocampal
neurons are dependent upon ethanol-induced increases in the GABAergic neuroactive
steroids (Tokunaga et al., 2003; VanDoren et al., 2000). These steroids substitute for ethanol
in discrimination studies in rodents and monkeys (Grant et al., 1996; Hodge et al., 2001;
Shannon et al., 2005) and exogenous administration can alter ethanol drinking patterns (Ford
et al., 2007; Janak et al., 1998; Morrow et al., 2001). All these studies have suggested that
neuroactive steroids mediate several behavioral effects of ethanol and contribute to ethanol
sensitivity.
The primary metabolite of ethanol, acetaldehyde, can also produce behavioral effects that
are similar to ethanol (for review Quertemont et al., 2005). For example, systemic
acetaldehyde administration causes a depression in locomotor activity (Myers et al., 1987),
impairment of spatial memory (Abe et al., 1999; Quertemont et al., 2004), ethanol-like
discrimination (Redila et al., 2002) and hypnotic effects (Quertemont et al., 2004). These
observations raise the possibility that acetaldehyde may contribute to GABAergic effects of
ethanol mediated by neuroactive steroids. While many behavioral effects have been studied,
few studies have examined acetaldehyde’s anxiolytic or anticonvulsant properties that are
dependent upon elevations of neurosteroids. Moreover, many of the experiments involving
acetaldehyde have relied upon direct administration of acetaldehyde into the brain or
systemic administration of high concentrations unlikely to be found physiologically. Thus,
the present study was designed to determine if physiologically relevant concentrations of
acetaldehyde contribute to the ethanol-induced increases in neuroactive steroid levels.
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Male Sprague-Dawley rats weighing between 250-350 g were used for all experiments
(Harlan, Indianapolis, IN). The animals were group housed (3 per cage) and maintained in
standard light and dark (lights on, 7:00 A.M. to 7:00 P.M.) conditions with food and water
available ad libitum. Rats were acclimated to the handling procedure for one week before
the test day. All experiments were conducted in accordance with the guidelines of the
National Institutes of Health Guide for the Care and Use of Laboratory Animals and
approved by the Institutional Animal Care and Use Committee of the University of North
Carolina Chapel Hill.
Drug administration
For steroid measurements, animals were sacrificed by decapitation 45 minutes after i.p.
administration of saline, ethanol (2 g/kg, 20% v/v), or acetaldehyde (20, 50, 75, 100 mg/kg).
4-methylpyrazole (200 mg/kg i.p.) was administered 60 minutes prior to ethanol to inhibit
alcohol dehydrogenase. Animals receiving catalase inhibitor, similar to prior studies
(Manrique et al., 2005), were administered sodium azide (10 mg/kg i.p.) 30 minutes prior to
an acute ethanol injection (2 g/kg, 20% v/v). To inhibit aldehyde dehydrogenase, animals
were administered cyanamide (50 mg/kg i.p.) 60 minutes prior to an acute ethanol injection
(2 g/kg, 20% v/v) (Jamal et al., 2005). Saline pretreated animals were used for controls in
both experiments. All experiments utilized a minimum of six animals per group.
Plasma ethanol and acetaldehyde measurements by gas chromatography
A 6 μl aliquot of plasma was analyzed for ethanol levels using a SRI 8610c gas
chromatograph (Torrance, CA). Acetaldehyde levels were determined using 100 μl of
plasma and in both instances similar volumes were used to establish a standard curve. The
ethanol standard curve ranged from 0 to 400 mg/dl and the acetaldehyde standard curve
ranged from 0 to 250 μM. Samples were distributed to tubes containing 375 μl of water and
0.5 g NaCl. Samples were heated in a water bath at 60 °C for 10 minutes and a 1.5 ml
sample of headspace gas was removed and injected directly into the GC. Samples were run
at 140 °C through a Hayesep D column and detected with a flame ionization detector.
Hydrogen gas, carrier gas, and internal air generator flow rates were 13.3, 25, and 250 ml/
min respectively. Areas under the curve were analyzed with SRI PeakSimple software and
converted to mg/dl for ethanol and μM for acetaldehyde based on the standard curves.
Radioimmunoassay (RIA) of neuroactive steroid 3α,5α-THP
RIAs were conducted as previously described (Janis et al., 1998). Briefly, brain samples
were weighed and suspended in 2.5 ml of 0.3N NaOH, homogenized with a sonic
dismembrator, and extracted three times with 3 ml aliquots of 10% ethyl acetate in heptane
(vol/vol). Extraction recovery was monitored by the addition of 2000 cpm of [3H] 3α,5α-
THP. The brain extracts were purified using solid phase silica columns (Burdick and
Jackson, Muskegon, MI) and subsequently dried. Samples were reconstituted and assayed in
duplicate by the addition of [3H] 3α,5α-THP and anti-3α,5α-THP antibody. Total binding
was determined in the absence of unlabeled 3α,5α-THP and nonspecific binding was
determined in the absence of antibody. The antibody binding reaction was allowed to
equilibrate for 2 hours and cold dextran coated charcoal was used to separate bound from
unbound steroid. Bound radioactivity was determined by liquid scintillation spectroscopy.
Steroid levels in the samples were extrapolated from a concurrently run standard curve and
corrected for their respective extraction efficiencies.
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Results are expressed as mean ± S.E.M. Steroid levels are expressed as ng/g for brain tissue.
Plasma ethanol levels are expressed as mg/dl and plasma acetaldehyde concentrations are
expressed in μM units. Significance was determined by one way ANOVA followed by post
hoc Newman Keuls test or the Student’s t test as appropriate. Analyses were performed
using the software GraphPad Prism version 4.
RESULTS
To determine the role of acetaldehyde in ethanol-induced increases in cerebral cortical 3α,
5α-THP levels, we first sought to ascertain the concentrations of acetaldehyde in plasma
following ethanol administration to rats. Rats were administered ethanol (2 g/kg) since this
dose produces near maximal effects on GABAergic neuroactive steroids and produces
prominent behavioral effects of ethanol. Plasma ethanol and acetaldehyde levels were
measured at various time points following ethanol administration. Plasma ethanol levels
peaked around 228 mg/dl (~50 mM) as quickly as 10 minutes post ethanol administration
and steadily declined over time (Fig. 1A). Plasma acetaldehyde levels remained relatively
constant at approximately 6-7 μM across the same time frame, while ethanol was
continuously metabolized (Fig. 1B). Furthermore, plasma and cerebral cortical 3α,5α-THP
levels were elevated at 45 minutes, corresponding to peak elevations in ethanol-induced
acetaldehyde levels (Fig. 1C).
To determine if the concentration of acetaldehyde produced by ethanol (2 g/kg) is capable of
producing an increase in 3α,5α-THP levels, we measured 3α,5α-THP in the cerebral cortices
of rats administered various doses of acetaldehyde. Various doses of acetaldehyde were used
because it was unknown what doses would produce relevant concentrations. Neuroactive
steroid levels were measured at 45 minutes, as this represents the timeframe of the peak
neurosteroid response to 2 g/kg ethanol. Figure 2 shows 3α,5α-THP and acetaldehyde levels
45 minutes post acetaldehyde administration from naïve animals (Fig. 2A,C) and animals
pretreated with the aldehyde dehydrogenase (ALDH) inhibitor cyanamide (Fig. 2B,D).
Cyanamide administration was necessary to delay acetaldehyde metabolism in order to
achieve concentrations similar to those observed following ethanol administration. In this
experiment, animals were pretreated with cyanamide 60 minutes prior to acetaldehyde
administration and compared to control animals pretreated with the inhibitor prior to saline.
Following cyanamide pretreatment, acetaldehyde administration increased 3α,5α-THP levels
at both the 75 mg/kg and the 100 mg/kg doses of acetaldehyde. However, these treatments
produced plasma acetaldehyde levels that were markedly higher than acetaldehyde
concentrations found after ethanol administration alone (Fig. 2D). At 50mg/kg, acetaldehyde
administration produced blood acetaldehyde concentrations similar to ethanol, but there was
no effect on cerebral cortical 3α,5α-THP levels.
While direct acetaldehyde administration is important to assess acetaldehyde’s effects,
experiments examining its effects after ethanol administration are necessary to determine
how acetaldehyde contributes to the ethanol response. Therefore, one strategy to study the
role of acetaldehyde in ethanol-induced increases in neuroactive steroids is to alter its
metabolism after ethanol administration. If acetaldehyde is involved, then systemic
manipulation of the enzymes involved in its metabolism should alter affects on 3α,5α-THP
levels following ethanol administration. Figure 3 shows cerebral cortical 3α,5α-THP levels
and the corresponding plasma ethanol and acetaldehyde concentrations for animals receiving
ethanol with and without prior inhibition of ALDH. 3α,5α-THP levels were increased
following ethanol administration compared to their respective controls regardless of ALDH
inhibition (Fig. 3A). Pretreatment with the ALDH inhibitor prior to ethanol administration
did not alter 3α,5α-THP levels compared to ethanol alone. In addition, the cyanamide
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pretreatment did not significantly alter steroid levels compared to saline pretreated controls.
Acetaldehyde levels were measured to confirm that the inhibitor was effective.
Acetaldehyde concentrations were increased 386.8 ± 35.1% following ALDH inhibition
compared to ethanol alone (Fig. 3C). Plasma ethanol levels were not significantly altered by
ALDH inhibition (Fig. 3B).
Next, we inhibited alcohol dehydrogenase and the catalase enzyme, which convert ethanol
to acetaldehyde in the liver and brain, respectively. Inhibition of alcohol dehydrogenase with
the competitive inhibitor 4-methylpyrazole (200 mg/kg) had no effect on 3α,5α-THP levels
compared to ethanol alone (Figure 4A). However, there was no detectable change in plasma
acetaldehyde concentrations, even though ethanol levels were increased from 195 mg/dl to
246 mg/dl and still elevated after 6 hours (data not shown). Furthermore, sodium azide
(10mg/kg) had no effect on ethanol-induced increases in. 3α,5α-THP levels (Fig. 4A). In
addition, sodium azide pretreatment did not significantly affect steroid levels compared to
saline pretreated controls. Plasma ethanol concentrations were slightly increased and plasma
acetaldehyde levels were decreased by 27.8 ± 8.8% following catalase inhibition when
compared to ethanol alone (Fig. 4B and 4C).
DISCUSSION
The current study was performed to address a previously unexplored issue of whether
acetaldehyde is involved in ethanol-induced increases in neuroactive steroids. Systemic
administration of 2 g/kg ethanol elicits an increase in neuroactive steroids that is not altered
by manipulation of ethanol metabolism. While high concentrations of acetaldehyde can
stimulate increases in neuroactive steroids, the administration of acetaldehyde at doses
eliciting concentrations similar to those produced after ethanol administration does not
increase neuroactive steroid levels. Taken together, these results indicate that ethanol is
primarily responsible for ethanol-induced increases in neuroactive steroids.
The most important factor in determining whether acetaldehyde contributes to ethanol-
induced increases in neuroactive steroids is to establish what concentration of acetaldehyde
exists in the blood following ethanol administration. Acetaldehyde levels remained
relatively steady across time and were low due to the high level of ALDH activity. Since
acetaldehyde is toxic, the body is very efficient at breaking it down and its clearance is much
larger than that of ethanol (Fujimiya et al., 2002). Next, the effect of acetaldehyde
administration at doses that produce similar concentrations was evaluated for their affect on
neuroactive steroid levels. It is important to keep in mind that the acetaldehyde levels
decline more rapidly following acetaldehyde vs ethanol administration since it is not
continuously formed and metabolized. Pretreatment with cyanamide stabilized acetaldehyde
levels across time to allow evaluation of acetaldehyde effects on 3α,5α-THP levels.
In the present study, plasma acetaldehyde concentrations were critical in determining the
role of acetaldehyde in ethanol-induced increases in neuroactive steroids. We used a dose of
ethanol (2g/kg) that produces peak increases in 3α,5α-THP levels. When plasma
acetaldehyde concentrations following systemic acetaldehyde administration were lower
than or comparable to levels observed following ethanol administration, no increase in 3α,
5α-THP levels was observed. However, when plasma acetaldehyde concentrations were
greater than levels following ethanol administration an increase in 3α,5α-THP levels was
detected.
Previous studies with acetaldehyde administration involve various routes of administration
as well as a variety of strains and species making it difficult to reliably compare results
across studies. However, in studies with systemic acetaldehyde administration, doses of at
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least 100 mg/kg were required to observe locomotor depression (Tambour et al., 2006) and
sedative and hypnotic effects (Quertemont et al., 2004). This is the same dose required to
elevate 3α,5α-THP levels in our study.
Indeed, we found that 100 mg/kg was the lowest acetaldehyde dose, without ALDH
inhibition, that increased 3α,5α-THP levels, despite producing low acetaldehyde levels
(approx 2.5 μM) compared to ethanol (7 μM). Since acetaldehyde is rapidly metabolized, its
concentration would be expected to be low after 45 minutes without ALDH inhibition.
Furthermore, when acetaldehyde levels were increased through ALDH inhibition, lower
doses of acetaldehyde were capable of increasing 3α,5α-THP levels and produced plasma
acetaldehyde concentrations greater than those seen after ethanol administration. This
strongly suggests the importance of acetaldehyde concentration in producing or contributing
to behavioral effects of ethanol.
When ethanol was administered to the rats, inhibition of ALDH increased acetaldehyde
levels, but did not have any increased effect on 3α,5α-THP levels in the cortex when
compared to animals treated with ethanol alone. However, the present results cannot rule out
the possibility that acetaldehyde may contribute to the elevation of neuroactive steroids via
synergistic actions with sub-maximal doses of ethanol. It is possible that very high
concentrations of acetaldehyde alone are required in order to elicit increases in neuroactive
steroids whereas lower doses, in conjunction with ethanol, may contribute to increased 3α,
5α-THP levels. Indeed, acetaldehyde has been shown to activate the hypothalamic-pituitary-
adrenal (HPA) axis (Kinoshita et al., 2001), which is involved in neuroactive steroid
synthesis. Furthermore, acetaldehyde is metabolized to acetate, which has also been shown
to have CNS effects, although these appear to involve locomotor actions mediated by
adenosine receptors (Carmichael et al., 1991).
The primary enzyme responsible for ethanol metabolism is alcohol dehydrogenase in the
liver. In addition to alcohol dehydrogenase, CYP2E1 and catalase are also involved in
ethanol metabolism. CYP2E1 is an inducible enzyme (Lieber and DeCarli, 1970) that plays
a more important role in dependent individuals than after acute ethanol exposure. The
catalase enzyme provides another pathway through which ethanol can be metabolized
(Aragon et al., 1992) and plays a significant role in ethanol metabolism in the brain.
Inhibition of catalase activity would be expected to have a marked effect on brain
acetaldehyde concentrations, however, catalase inhibition did not affect cerebral cortical 3α,
5α-THP levels in these experiments. Inhibition of alcohol dehydrogenase also failed to elicit
any changes in 3α,5α-THP levels. However, inhibition of alcohol dehydrogenase activity is
not as favorable for determining acetaldehyde’s role in ethanol’s effects because brain
alcohol dehydrogenase activity is very low (Beisswenger et al., 1985).
The lack of effect of 4-methylpyrazole on acetaldehyde levels raises some concern.
However, others have reported that inhibition of alcohol dehydrogenase fails to alter plasma
acetaldehyde levels in the absence of an ALDH inhibitor (Quertemont and Didone, 2006).
Since ethanol levels were increased up to 6 hrs following 4-methylpyrazole administration,
we presume that alcohol dehydrogenase was inhibited. Changes in acetaldehyde levels may
approach the limit of detection following 4-methylpyrazole administration. However, we are
able to detect dose-dependent acetaldehyde levels following acetaldehyde administration as
well as the expected increases when ALDH is inhibited. Hence, it is reasonable to conclude
that ethanol-induced increases in 3α,5α-THP levels are independent of acetaldehyde. The
lack of effect of 4-methylpyrazole on ethanol-induced increases in 3α,5α-THP levels also
suggests that NADH/NAD+ redox changes secondary to ethanol metabolism are not
involved in this effect of ethanol. To date, there are not consistent results for alterations in
alcohol dehydrogenase activity affecting ethanol consumption patterns, suggesting that
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ALDH activity and acetaldehyde levels are important factors in regulating drinking
behaviors.
Acetaldehyde has been implicated in some of the behavioral effects of ethanol although the
precise role and mechanism of action remain unclear. Importantly, direct administration of
acetaldehyde results in some of the same behavioral effects as ethanol providing a basis for
the idea that acetaldehyde contributes to behavioral effects following ethanol administration.
However, many experiments used higher concentrations of acetaldehyde then what would be
expected from endogenous ethanol metabolism. Therefore, experiments conducted here
focused on the effects of physiologically relevant acetaldehyde concentrations on 3α,5α-
THP levels. Interestingly, when plasma acetaldehyde concentrations were comparable to
levels found after ethanol administration there was no increase in cerebral cortical 3α,5α-
THP levels suggesting that acetaldehyde is not responsible for ethanol-induced increases in
neuroactive steroids.
While these studies were performed in a rat model, the results may be applicable to humans.
Adolescent males and females seen in the emergency room for alcohol intoxication had
substantial increases in plasma levels of the neuroactive steroid 3α,5α-THP (Torres and
Ortega, 2003; Torres and Ortega, 2004). Furthermore, various subjective effects of ethanol
are diminished by prior administration of the neurosteroid biosynthesis inhibitor finasteride
(Pierucci-Lagha et al., 2005). In contrast, laboratory administration of low or moderate
ethanol doses had no effect on plasma 3α,5α-THP levels (Holdstock et al., 2006) or
decreased 3α,5α-THP levels (Nyberg et al., 2005; Pierucci-Lagha et al., 2006). Though an
explanation for these conflicting results is unresolved, the potential role of neurosteroids in
human alcohol sensitivity has not been ruled out.
The present results support the theory that acetaldehyde modulates some of ethanol’s effects
rather than mediating them. However, the finding that high acetaldehyde concentrations can
increase neuroactive steroid levels leaves open the possibility that acetaldehyde could
contribute to neurosteroid elevations after large quantities of ethanol consumption. Indeed,
the extent of acetaldehyde’s effects would vary between individuals depending upon the
respective activities of their alcohol metabolizing enzymes and the amount of ethanol
consumed. For example, human studies have noted that Native American populations, which
have high rates of alcohol abuse and dependence, have polymorphisms in alcohol
metabolizing enzymes that may account for drinking behaviors (Wall et al., 2003). Other
studies have suggested that high peripheral acetaldehyde concentrations are aversive and
individuals with mutations in their ALDH2 gene metabolize acetaldehyde less rapidly and
subsequently have a lower risk of developing alcoholism (for review Quertemont, 2004). In
addition, animals with high ALDH activity have less acetaldehyde in their blood and tend to
drink more ethanol (Quintanilla et al., 2005) while animals administered an adenoviral
vector containing an ALDH2 antisense gene have reduced ALDH2 activity and reduced
ethanol consumption (Ocaranza et al., 2008). Furthermore, ALDH2 knockout mice have
increased blood acetaldehyde concentrations and drink less (Isse et al., 2005; Isse et al.,
2002).
While speculative, it is intriguing to suggest a relationship between acetaldehyde and
neuroactive steroids in risk for alcoholism. The production of neurosteroids is associated
with an increased sensitivity to ethanol in rodents (for review Morrow et al., 2006) and
possibly humans (Pierucci-Lagha et al., 2005). In the present study, high concentrations of
acetaldehyde, which are associated with reduced drinking and risk for alcoholism, also
increased neuroactive steroids. This effect may contribute to increased ethanol sensitivity
and the decreased the risk for alcoholism. Therefore, while physiological concentrations of
acetaldehyde do not appear to be responsible for ethanol-induced increases in neuroactive
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steroids in rats, the potential role of acetaldehyde cannot be excluded from contributing to
ethanol actions. Further studies will be necessary to clarify the importance of acetaldehyde
in the effects of ethanol.
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Fig. 1. Time-course of plasma ethanol and acetaldehyde concentrations following ethanol
administration
Animals were administered a 2 g/kg dose of ethanol and blood was collected at varying time
points. (A) Plasma ethanol and (B) acetaldehyde levels were measured via gas
chromatography. Ethanol and acetaldehyde are rapidly increased and then acetaldehyde
levels stabilize as ethanol is metabolized. (C) 3α,5α-THP levels were increased in both the
plasma and the cerebral cortex 45 minutes after ethanol administration. Plasma 3α,5α-THP
levels are measured as ng/ml and brain as ng/g. *p<0.01 compared to controls, n=4-8 in
duplicate.
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Fig. 2. Acetaldehyde administration to levels that mimic ethanol metabolism do not increase 3α,
5α-THP levels in cortex
(A) Acetaldehyde was administered in varying doses and brains were collected after 45
minutes to measure cortical levels of 3α,5α-THP. (B) The same concentrations of
acetaldehyde were administered to rats pretreated with the ALDH inhibitor cyanamide (50
mg/kg) 60 minutes prior to acetaldehyde administration and cortical 3α,5α-THP was
measured. Plasma acetaldehyde concentrations were measured in (C) animals receiving
acetaldehyde alone and in (D) animals receiving the inhibitor prior to acetaldehyde
administration. 3α,5α-THP levels were measured by RIA and acetaldehyde concentrations
via gas chromatography. *p<0.001 compared to controls, n=6 for control and n=8 for
acetaldehyde groups in duplicate.
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Fig. 3. Effect of pretreatment with the aldehyde dehydrogenase inhibitor cyanamide on ethanol-
induced 3α,5α-THP elevation
Animals were administered cyanamide (50 mg/kg, i.p.) 60 minutes prior to an acute
injection of ethanol or saline and steroids were measured 45 minutes following the
injections. (A) 3α,5α-THP levels were increased in the rat cerebral cortex after acute ethanol
(2 g/kg, i.p.) administration and were not affected by treatment with an aldehyde
dehydrogenase inhibitor. (B) Plasma alcohol levels were unaffected by aldehyde
dehydrogenase inhibition while (C) plasma acetaldehyde levels were increased. *P < 0.001
compared to controls, n=6 in duplicate.
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Fig. 4. Effects of pretreatment with 4-methylpyrazole and sodium azide on ethanol-induced 3α,
5α-THP elevation
Animals were administered 4-methylpyrazole (200mg/kg, i.p.) or sodium azide (10 mg/kg,
i.p.) prior to an acute injection of ethanol or saline and steroids were measured 45 minutes
following injections. (A) 3α,5α-THP levels were increased in the rat cerebral cortex after
acute ethanol (2 g/kg, i.p.) administration and were not affected by treatment with either
inhibitor. (B) Plasma alcohol levels were increased in animals receiving the catalase
inhibitor and (C) plasma acetaldehyde concentrations were decreased when catalase was
inhibited. *P < 0.05 compared to controls, n=6 in duplicate.
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